therapy group:Cell reinfusion

2 trials

Sponsors

Beijing Boren Hospital

Conditions

Children and adolescents have difficulty recovering mature B-cell lymphomaRelapsed or refractory CD19-positive non-Hodgkin's lymphoma

Phase 1

Phase I clinical study of dual-antigen-targeted CART combined with single-antigen-targeted CART for sequential treatment of children and adolescents with refractory and relapsed mature B-cell lymphoma

RecruitingChiCTR2100045864

Beijing Boren HospitalChildren and adolescents have difficulty recovering mature B-cell lymphoma

Start: 2021-04-30Updated: 2021-12-13

A clinical study to evaluate the safety and effectiveness of IM19CAR-T cells in the treatment of patients with relapsed or refractory CD19-positive non-Hodgkin's lymphoma

RecruitingChiCTR2100045919

Beijing Boren HospitalRelapsed or refractory CD19-positive non-Hodgkin's lymphoma

Start: 2021-04-30Updated: 2021-12-13